Fingerprint
Dive into the research topics of 'Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period
Leanne M Ward*, Wolfgang Högler, Francis H Glorieux, Anthony A Portale, Michael P Whyte, Craig F Munns, Ola Nilsson, Jill H Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Etienne Sochett, Koji Muroya, Hiroyuki Tanaka, Pisit Pitukcheewanont, Gary S Gottesman, Andrew Biggin, Farzana Perwad, Angel Chen, John Lawrence Merritt II
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
77
Downloads
(Pure)